However, a recent retrospective study in Japan did not report an increased risk of acute kidney injury after a short-term follow-up of 7–30 days following intravitreal VEGF injection in patients with diabetes and chronic kidney disease [22]. Here, VEGFA is linked to acute kidney injury.